3
Nov
2026
The AI Moment in Drug Discovery: Daphne Koller on The Long Run
Daphne Koller is today’s guest on The Long Run. Daphne is the founder and CEO of South San Francisco-based Insitro. It’s one of what you could call the first-generation companies that uses AI to speed up and improve drug discovery. Insitro was founded in 2018 and has secured $750 million in funding from venture capital firms and through partnerships with... Read More
